skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Search for: All records

Creators/Authors contains: "Kim, Kyunghwan"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. Combination therapies using checkpoint inhibitors with immunostimulatory agonists have attracted great attention due to their synergistic therapeutic effects for cancer treatment. However, such combination immunotherapies require specific timing of doses to show sufficient antitumor efficacy. Sequential treatment usually requires multiple administrations of the individual drugs at specific time points, thus increasing the complexity of the drug regimen and compromising patient compliance. Here, we introduce an injectable porous silicon microparticle (pSiMP) for combination cancer immunotherapy where its multilayered nanopore structure was electrochemically programmed to achieve release of three distinct immunomodulatory drugs in the right sequence at the desired time. We find the optimal sequential treatment timeline of stimulator of interferon genes (STING) agonist, anti-OX40 antibody (aOX40), and anti-PD-1 antibody (aPD-1) for immunosuppressive tumors. We show that a single intratumoral injection of a cocktail of release-programmed pSiMPs coloaded with each antibody and a STING agonist significantly suppresses the tumor growth compared to conventional treatment involving sequential bolus injections, or an injection of pSiMPs configured to release all drugs at the same time, with no delay. With the timely release of immunomodulatory drugs, the programmable pSiMPs offer an effective treatment strategy for combination immunotherapy. 
    more » « less
    Free, publicly-accessible full text available February 5, 2026
  2. Abstract Nonlinear microscopy provides excellent depth penetration and axial sectioning for 3D imaging, yet widespread adoption is limited by reliance on expensive ultrafast pulsed lasers. This work circumvents such limitations by employing rare‐earth doped upconverting nanoparticles (UCNPs), specifically Yb3+/Tm3+co‐doped NaYF4nanocrystals, which exhibit strong multimodal nonlinear optical responses under continuous‐wave (CW) excitation. These UCNPs emit multiple wavelengths at UV (λ ≈ 450 nm), blue (λ ≈ 450 nm), and NIR (λ ≈ 800 nm), whose intensities are nonlinearly governed by excitation power. Exploiting these properties, multi‐colored nonlinear emissions enable functional imaging of cerebral blood vessels in deep brain. Using a simple optical setup, high resolution in vivo 3D imaging of mouse cerebrovascular networks at depths up to 800 µmm is achieved, surpassing performance of conventional imaging methods using CW lasers. In vivo cerebrovascular flow dynamics is also visualized with wide‐field video‐rate imaging under low‐powered CW excitation. Furthermore, UCNPs enable depth‐selective, 3D‐localized photo‐modulation through turbid media, presenting spatiotemporally targeted light beacons. This innovative approach, leveraging UCNPs' intrinsic nonlinear optical characteristics, significantly advances multimodal nonlinear microscopy with CW lasers, opening new opportunities in bio‐imaging, remote optogenetics, and photodynamic therapy. 
    more » « less